ADMA

Insider trade Purchase by Grossman Jerrold B

4d ago

News Adma Biologics (ADMA) Stock Falls Amid Market Uptick: What Investors Need to Know

14d ago

News Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It?

14d ago

Insider trade Purchase by Jerrold B Grossman

19d ago

Insider trade Purchase by Jerrold B Grossman

20d ago

News Adma projects 2026 revenue of $530M-$560M and withdraws longer-term guidance amid standard IG dislocation

26d ago

News ADMA Biologics GAAP EPS of $0.19 in-line, revenue of $114.5M misses by $25.47M

26d ago

SEC filing ADMA Reports FDA Approval Expanding ASCENIV Label to Pediatric Patients 2+ Years, $12M Revenue, +15% YoY Growth

29d ago

News Summers Value Fund adds TBPH, exits ADMA among Q1 moves

34d ago

News ADMA Biologics drops amid short report from Culper Research

69d ago

Insider trade Sale by Adam S Grossman (President and CEO)

76d ago

Insider trade Sale by Kaitlin M. Kestenberg-Messina (COO and SVP, Compliance)

83d ago

Insider trade Purchase by ELMS STEVE

85d ago

News ADMA Biologics announces $125M accelerated share repurchase with JPmorgan

92d ago

Insider trade Sale by Adam S Grossman (President and CEO)

104d ago

News Archer Daniels Midland's Q4 results reflect headwinds from biofuel and trade policies

119d ago

News Archer Daniels Profit, Revenue Fall on Biofuel Policy and Trade Uncertainty

119d ago

News ADMA Biologics reports FY 2025 revenue in line with estimate, provides 2026–2029 outlook

141d ago